This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1993 Mar 3;85(5):346-7.

doi: 10.1093/jnci/85.5.346.

Taxol in advanced non-small-cell lung cancer: plus Ca change?

PMID: 8094465
DOI: 10.1093/jnci/85.5.346

Editorial

Taxol in advanced non-small-cell lung cancer: plus Ca change?

E A Eisenhauer. J Natl Cancer Inst. 1993.

. 1993 Mar 3;85(5):346-7.

doi: 10.1093/jnci/85.5.346.

Author

PMID: 8094465
DOI: 10.1093/jnci/85.5.346

No abstract available

PubMed Disclaimer

Comment on

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer.
Murphy WK, Fossella FV, Winn RJ, Shin DM, Hynes HE, Gross HM, Davilla E, Leimert J, Dhingra H, Raber MN, et al. Murphy WK, et al. J Natl Cancer Inst. 1993 Mar 3;85(5):384-8. doi: 10.1093/jnci/85.5.384. J Natl Cancer Inst. 1993. PMID: 8094466 Clinical Trial.
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.
Chang AY, Kim K, Glick J, Anderson T, Karp D, Johnson D. Chang AY, et al. J Natl Cancer Inst. 1993 Mar 3;85(5):388-94. doi: 10.1093/jnci/85.5.388. J Natl Cancer Inst. 1993. PMID: 8094467 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information